Toshihiro Okuya
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
A case of diffuse large B-cell lymphoma achieving complete remission with epcoritamab after pseudoprogression.
Journal: Journal of clinical and experimental hematopathology : JCEH
Published: August 30, 2026
Concurrent tumor lysis syndrome and 5-fluorouracil encephalopathy during the first cycle of zolbetuximab plus mFOLFOX6 for CLDN18.2-positive gastric cancer: a case report.
Journal: International cancer conference journal
Published: July 07, 2025
Site- and Stage-Adapted Treatment Strategies for Gastrointestinal Diffuse Large B-Cell Lymphoma.
Journal: European journal of haematology
Published: April 10, 2025
Successful Conversion Surgery for Unresectable Microsatellite Instability-High Pancreatic Tail Cancer Following Pembrolizumab Therapy.
Journal: Surgical case reports
Published: March 31, 2025
Early failure is still a poor prognostic factor in patients with relapsed or refractory large B-cell lymphoma in the era of CAR T-cell therapy.
Journal: Journal of clinical and experimental hematopathology : JCEH
Published: June 26, 2024
Management of HER2-positive and microsatellite instability-high advanced gastric cancer: a case report.
Journal: International cancer conference journal
Published: May 24, 2024
A Case of a Two-Stage Robotic-Assisted Surgery for a Neuroendocrine Tumor of the Pancreatic Tail with Simultaneous Single Liver Metastasis
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: February 02, 2024
Curative Resection after Chemotherapy for Advanced Extensive Cholangiocarcinoma-A Case Report
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: February 02, 2024
Therapeutic target biomarkers of patient-derived xenograft models of gastric-type cervical adenocarcinoma.
Journal: Gynecologic oncology reports
Published: September 26, 2023
Polatuzumab vedotin, bendamustine, and rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma, including the outcome as a bridging treatment to CAR-T cell therapy or allogeneic hematopoietic stem cell transplant
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: August 06, 2023
Hemoglobin-platelet index as a prognostic factor in patients with peripheral T-cell lymphoma.
Journal: EJHaem
Published: February 17, 2023
Utility of the frailty score for predicting prognosis and individualizing treatment intensity in elderly patients with diffuse large B cell lymphoma.
Journal: Annals of hematology
Published: February 11, 2023
Last Updated: 09/26/2026